{
  "id": 12219613,
  "title": "Freedom Broker cuts NioCorp stock price target on funding dilution",
  "url": "https://urgent.news/2026/10/05/freedom-broker-cuts-niocorp-stock-price-target-on-funding-dilution",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-05T19:52:55.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/analyst-ratings/freedom-broker-cuts-niocorp-stock-price-target-on-funding-dilution-93CH-4932784"
  },
  "original_language": "en",
  "account": "Freedom Broker has reduced its price target for NioCorp Developments Ltd. (NASDAQ:NB) shares to $8.40 from $12.00. This adjustment comes after reviewing the company's FY2026 10-K filing and discussions with management regarding the Elk Creek project's funding structure. Analyst Vitaly Kononov explained that the firm now factors in the equity NioCorp still needs to raise, estimated at $489 million, which would equate to approximately 90 million new shares priced at an average of $5.40 each. The firm also considers the EXIM facility to be 65% of upfront capital expenditures, aligning with management's indication of a $1.2 billion to $1.3 billion requirement. As of now, NioCorp's stock is trading at $0.06, close to its 52-week low of $0.05. InvestingPro analysis suggests that the stock may still be undervalued, with a Fair Value calculation indicating potential upside. The company's financial health score stands at 3.36, with more cash than debt on its balance sheet, suggesting a positive outlook as it pursues the capital raise. Investors can find additional valuation metrics and 5 more InvestingPro Tips on a list of the most undervalued stocks. Peer multiples have also tightened since Freedom Broker's last update on the stock. NioCorp Developments Ltd. has recently been the subject of multiple significant updates, including coverage from Jefferies, which rated the stock a Hold with a price target of $4.70 due to uncertainty around financing, and H.C. Wainwright, which maintained a Buy rating with a $10.00 price target, expressing increased confidence in the company's potential to secure a debt financing decision soon. Additionally, NioCorp is reportedly in talks with Lockheed Martin to supply scandium, a critical mineral for military equipment, as part of a broader push by the U.S. government to support domestic critical mineral projects. These developments, along with others, may significantly impact NioCorp's future operations, keeping investors closely monitoring the situation.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}